Glycopyrrolate Injection
Product Images NDC 0781-3829

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0781-3829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Glycopyrrolate Injection 01)

FDA Label Image

Glycopyrrolate-carton-1ml (Glycopyrrolate Injection 02)

Glycopyrrolate-carton-1ml (Glycopyrrolate Injection 02)
This is a description of a medication called Glycopyrrolate Injection, USP, which is contained in a single-dose vial of 251 mL. It is intended for use via intramuscular or intravenous injection and contains benzyl alcohol. The medication is not recommended for use in newborns.*
FDA Label Image

Glycopyrrolate-carton-2ml (Glycopyrrolate Injection 03)

Glycopyrrolate-carton-2ml (Glycopyrrolate Injection 03)
This is a description of a medication called Glycopyrrolate Injection, USP, which is provided in single-dose vials. The medication has a concentration of 0.2mg/ml and contains benzy alcohol for intramuscular or intravenous use. It is indicated for use in newborns.*
FDA Label Image

Glycopyrrolate-carton-5ml (Glycopyrrolate Injection 04)

Glycopyrrolate-carton-5ml (Glycopyrrolate Injection 04)
This is a product description for Glycopyrrolate Injection, USP available in 0.2 mg/ml concentration which is used for intramuscular or subcutaneous injection. The package contains 25 vials, each with 5mL capacity. It also mentions that the product contains benzyl alcohol.*
FDA Label Image

Glycopyrrolate-carton-20ml (Glycopyrrolate Injection 05)

Glycopyrrolate-carton-20ml (Glycopyrrolate Injection 05)
This is a description of Glycopyrrolate Injection, USP, a medication that comes in 10 x 20 mL multiple-dose vials. It contains benzyl alcohol and is intended for intramuscular or intravenous use only. It should be stored at 20° to 25°C and should be kept out of the reach of children. The text also provides NDC codes for the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.